LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent.
Increased polyamine production is observed in a variety of chronic neuroinflammatory disorders, but in vitro and in vivo studies yield conflicting data on the immunomodulatory consequences of their production. Ornithine decarboxylase (ODC) is the rate-limiting enzyme in endogenous polyamine production. To identify the role of polyamine production in CNS-intrinsic inflammatory responses, we defined CNS sites of ODC expression and the consequences of inhibiting ODC in response to intracerebral injection of LPS±IFNγ. In situ hybridization analysis revealed that both neurons and non-neuronal cells rapidly respond to LPS±IFNγ by increasing ODC expression. Inhibiting ODC by co-injecting DFMO decreased LPS-induced CCL2 expression and macrophage influx into the CNS, without altering LPS-induced microglial or macrophage activation. Conversely, intracerebral injection of polyamines was sufficient to trigger macrophage influx into the CNS of wild-type but not CCL2KO mice, demonstrating the dependence of macrophage influx on CNS expression of CCL2. Consistent with these data, addition of putrescine and spermine to mixed glial cultures dramatically increased CCL2 expression and to a much lesser extent, TNF expression. Addition of all three polyamines to mixed glial cultures also decreased the numbers and percentages of oligodendrocytes present. However, in vivo, inhibiting the basal levels of polyamine production was sufficient to induce expression of apolipoprotein D, a marker of oxidative stress, within white matter tracts. Considered together, our data indicate that: (1) CNS-resident cells including neurons play active roles in recruiting pro-inflammatory TREM1-positive macrophages into the CNS via polyamine-dependent induction of CCL2 expression and (2) modulating polyamine production in vivo may be a difficult strategy to limit inflammation and promote repair due to the dual homeostatic and pro-inflammatory roles played by polyamines.
Division of Biomedical Sciences, Center for Glial-Neuronal Interactions, University of California, Riverside, CA, USA.
Shweta S
SS
Puntambekar
Deirdre S
DS
Davis
Leo
L
Hawel
Janelle
J
Crane
Craig V
CV
Byus
Monica J
MJ
Carson
D000818:Animals; D002478:Cells, Cultured; D002490:Central Nervous System / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D018932:Chemokine CCL2 / Q000235:genetics / Q000378:metabolism*; D007276:Injections, Intraventricular; D007371:Interferon-gamma / Q000008:administration & dosage; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000276:immunology; D008264:Macrophages / Q000166:cytology / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D011700:Putrescine / Q000378:metabolism*; D011971:Receptors, Immunologic / Q000378:metabolism*; D013095:Spermidine / Q000378:metabolism; D013096:Spermine / Q000378:metabolism; D000073871:Triggering Receptor Expressed on Myeloid Cells-1
C491768:Ccl2 protein, mouse; D018932:Chemokine CCL2; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic; C517262:TREM1 protein, mouse; D000073871:Triggering Receptor Expressed on Myeloid Cells-1; D013096:Spermine; D007371:Interferon-gamma; D009955:Ornithine Decarboxylase; D013095:Spermidine; D011700:Putrescine
FASEB J. 2009 Sep;23(9):2888-97
19417083
Neuroscience. 2004;128(4):741-9
15464282
Aging Cell. 2008 Aug;7(4):506-15
18419796
J Immunol. 1994 Mar 15;152(6):3039-52
8144903
Cell Mol Life Sci. 2001 Feb;58(2):244-58
11289306
Am J Pharmacogenomics. 2004;4(5):321-30
15462610
J Neurosci Res. 1999 Jan 1;55(1):127-34
9890441
Neurosci Lett. 1995 Sep 1;197(1):5-8
8545054
Neuron. 2006 Feb 16;49(4):489-502
16476660
IUBMB Life. 2009 Sep;61(9):880-94
19603518
J Anat. 2004 Jan;204(1):49-55
14690477
Biochem J. 1997 Jul 15;325 ( Pt 2):289-97
9230104
Clin Nutr. 2005 Apr;24(2):184-97
15784477
FASEB J. 2004 Jul;18(10):1114-6
15132986
J Neurosci Res. 2001 Feb 15;63(4):303-12
11170180
Am J Physiol. 1999 Jul;277(1):E110-7
10409134
J Neurochem. 2006 Jul;98(2):471-80
16805840
Can J Neurol Sci. 2009 Jan;36(1):14-9
19294882
J Cell Biol. 2003 Jul 21;162(2):257-68
12860970
Shock. 2000 Aug;14(2):144-9
10947158
Brain Res Bull. 1986 Sep;17(3):307-20
3094839
Br J Pharmacol. 2009 Aug;157(8):1301-17
19594762
Br J Pharmacol. 1996 Apr;117(8):1803-8
8732295
Science. 2010 Nov 5;330(6005):783-8
21051630
Neurotherapeutics. 2007 Oct;4(4):571-9
17920538
Drug Discov Today Dis Models. 2008;5(1):19-25
19444332
Science. 2010 Nov 5;330(6005):841-5
20966214
Glia. 1998 Jan;22(1):72-85
9436789
J Gen Physiol. 2005 Apr;125(4):413-26
15795311
Prog Neurobiol. 1999 Apr;57(5):485-505
10215098
J Neurosci Res. 2007 Feb 15;85(3):594-601
17171700
J Biol Chem. 1998 Jul 31;273(31):19490-4
9677370
Neuropharmacology. 1991 Jun;30(6):567-73
1656301
Neuron. 2004 Nov 18;44(4):609-21
15541310
Neurochem Int. 2006 Feb;48(3):201-7
16290266
Brain Res. 2003 Aug 15;981(1-2):118-25
12885432
Exp Cell Res. 2008 Aug 15;314(14):2603-17
18586028
Crit Care Med. 2000 Apr;28(4 Suppl):N60-6
10807317
Neuron. 2002 Aug 15;35(4):711-9
12194870
Clin Exp Metastasis. 2004;21(5):461-7
15672871
J Neurosci Res. 1993 Feb 15;34(3):287-94
8384267
Nat Med. 2007 Apr;13(4):432-8
17351623
J Neurochem. 2009 May;109 Suppl 1:117-25
19393017
Amino Acids. 2004 Jul;26(4):353-65
15290341
ASN Neuro. 2010 Jul 12;2(3):e00037
20640189
Br J Pharmacol. 1994 Jun;112(2):355-6
7521253
J Neurosci. 2009 Jul 29;29(30):9545-52
19641117
J Neurochem. 1998 Jul;71(1):288-94
9648877
J Biol Chem. 2005 Jan 28;280(4):2409-12
15548540